Pear Therapeutics- Warrants (01/12/2026) Current Cash

The latest current cash for PEARW is $48M as of December 2022. That compares with $170M in the prior-year period — down 71.5% year over year. Investors often review this figure alongside Pear Therapeutics- Warrants (01/12/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PEARW's current cash moved from $170M to $48M — a 71.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pear Therapeutics- Warrants (01/12/2026)'s operating scale or balance-sheet position.

A current cash figure of $48M for PEARW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PEARW's current cash ($48M), review year-over-year change from $170M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.